The Effect of 40 Hz Transcranial Stimulation on the Incidence of Delirium After Total Hip Replacement or Total Knee Replacement Arthroplasty in Elderly Patients

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Delirium is an acute confusional state, it is a sign of acute encephalopathy, also known as acute brain failure, acute brain dysfunction or mental state changes.Postoperative delirium can cause post-traumatic stress disorder, affects patients' quality of life, extend the length of hospital stay, increased hospitalization cost, and is closely relative to short-term and long-term mortality after surgery. Exogenous 40 Hz stimulation can improve cognitive functioning. Therefore, the aim of this study was to investigate the effect of exogenous 40Hz stimulation on the incidence of postoperative delirium in elderly patients undergoing hip and knee replacement.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Maximum Age: 85
Healthy Volunteers: f
View:

• 65-85 years old, gender not limited 2.General anesthesia unilateral total hip replacement surgery or unilateral total knee replacement 3.ASA classification I-III 4.No drugs for mental and central nervous system diseases were used before surgery 5.Preoperative MMSE score illiterate \> 17 points, primary \> 20 points, junior high school and above \> 24 points 6.Obtaining informed consent

Locations
Other Locations
China
Henan People's Hospital
RECRUITING
Zhengzhou
Contact Information
Primary
Zhang jiaqiang
hnmzxh@163.com
037165580728
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2025-03-15
Participants
Target number of participants: 110
Treatments
Experimental: 40Hz stimulation group
At the start of anesthesia, the subject received 40Hz transcranial stimulation for 1h.
No_intervention: Control group
At the start of anesthesia, the subject did not receive any additional treatment.
Sponsors
Leads: Henan Provincial People's Hospital

This content was sourced from clinicaltrials.gov